Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
09/2014
09/18/2014US20140271470 Targeted theranostics for metastatic prostate cancer
09/18/2014US20140271469 Cystine knot peptides that bind alpha-v-beta-6 integrin
09/18/2014US20140271468 Asthma imaging
09/18/2014US20140271467 Probes and methods of imaging non-hodgkins lymphoma
09/18/2014US20140271466 HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation
09/18/2014US20140271465 Matrix metalloprotease (mmp) targeted agents for imaging and therapy
09/18/2014US20140271463 Bri2 as a novel biomarker for alzheimer's disease
09/18/2014US20140271462 Antigen binding constructs to cd8
09/18/2014US20140271461 Compositions and associated methods for radioisotope-binding microparticles
09/18/2014US20140271460 Highly Active Anti-Neoplastic and Anti-Proliferative Agents
09/18/2014US20140271456 Radiotracer imaging using sodium iodide symporter polypeptides
09/17/2014EP2775906A1 Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging
09/16/2014US8835605 Uses of cancer-targeting peptides in cancer diagnosis
09/16/2014US8835395 Protein peptide hydrogels
09/16/2014US8835167 Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors
09/16/2014US8835126 Tritiated planar carbon forms
09/16/2014US8834885 Methods for identification of sites for IgG conjugation
09/16/2014US8834883 Anti-VEGF antibodies and uses thereof
09/16/2014US8834843 Imaging method
09/16/2014US8834842 Vitamin-targeted imaging agents
09/16/2014US8834841 Imaging agents
09/16/2014US8834840 Magnetic resonance imaging of self-assembled biomaterial scaffolds
09/16/2014US8834839 Labeled molecular imaging agents, methods of making and methods of use
09/16/2014US8834838 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
09/16/2014US8834837 Method and device for radiotherapy
09/16/2014US8833631 Delivery applicator for radioactive staples for brachytherapy medical treatment
09/16/2014CA2675202C Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
09/16/2014CA2583367C Cytotoxic formulation for combination therapy
09/12/2014WO2014135860A1 Methods, unit and device relating to the manufacture, processing, synthesising or screening of radiopharmaceutical compositions
09/12/2014WO2014135590A1 Metallocene compounds and labeled molecules comprising the same for in vivo imaging
09/12/2014WO2014134716A1 Substituted organofluoroborates as imaging agents
09/11/2014US20140257096 Data-driven optimization of event acceptance/rejection logic
09/11/2014US20140256916 Immuno imaging agent for use with antibody-drug conjugate therapy
09/11/2014US20140255410 Specific binding proteins and uses thereof
09/11/2014US20140255308 6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN
09/11/2014US20140255305 Immuno imaging agent for use with antibody-drug conjugate therapy
09/11/2014US20140255304 Tdp-43 specific binding molecules
09/11/2014US20140255303 Anti-vcam-1 nanobodies
09/11/2014US20140255298 Radiopaque markers for implantable medical leads
09/10/2014EP2774930A1 Metallocene compounds and labeled molecules comprising the same for in vivo imaging.
09/09/2014US8831891 Direct solid sample analytical technology for determining a content and a uniformity thereof in a lyophilized kit of a sulfur-containing chelator with a stable complex capacity for radiotechnetium (Tc-99M) and radiorhenium (Re-186, Re-188)
09/09/2014US8828355 Imaging reporters of transgene expression
09/09/2014US8828354 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
09/09/2014US8827884 Oncology therapies employing radioactive seeds
09/09/2014CA2436242C Biotin-derivatives and their conjugates with chelating agents
09/04/2014US20140249350 Apparatus for fractionation and infusion of radiopharmaceutical products
09/04/2014US20140248213 Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties
09/04/2014US20140248212 Non-immunogenic positron emission tomography reporter gene systems
09/04/2014US20140248210 Multimodal silica-based nanoparticles
09/04/2014US20140248209 Anti-tumoral compound and relative production process
09/03/2014EP2771688A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
09/03/2014EP2771037A2 Therapeutic agents and uses thereof
09/02/2014US8822637 Somatostatin analogues
09/02/2014US8822545 Tannin formulation for treating gastrointestinal spasms triggered by stress
09/02/2014US8822544 Tannin formulation for treating gastrointestinal spasms in a subject having colorectal cancer
09/02/2014US8821873 Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
09/02/2014US8821849 Internal clamp for surgical procedures
09/02/2014US8821835 Flexible and/or elastic brachytherapy seed or strand
09/02/2014CA2413866C Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
08/2014
08/28/2014US20140241986 Formulations of fluorinated stilbene suitable for pet imaging
08/28/2014US20140241985 Chelated PSMA Inhibitors
08/26/2014US8815804 Methods and compositions related to targeting tumors and wounds
08/26/2014US8815213 RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors
08/26/2014CA2582252C Therapeutic use of anti-tf-antigen antibody
08/26/2014CA2523620C Drug releasing biodegradable fiber for delivery of therapeutics
08/21/2014US20140235924 Method of radiotherapy
08/21/2014US20140235861 Method for the synthesis of 18f-labelled biomolecules
08/21/2014US20140235790 Carbohydrate-based compositions and methods for targeted drug delivery
08/21/2014US20140234217 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers
08/21/2014US20140234216 Folate conjugates of albumin-binding entities
08/21/2014US20140234214 Methods of Treating a Tauopathy
08/21/2014US20140234211 Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents
08/21/2014US20140234210 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
08/20/2014EP2767532A1 Novel compound for imaging tau protein accumulated in the brain
08/19/2014US8809399 Methods of treating gastrointestinal spasms triggered by stress
08/19/2014US8808691 Method for treating tumors and their metastases
08/19/2014US8808665 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
08/19/2014US8808664 Lipidated glycoprotein particles and methods of use
08/19/2014CA2651285C Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
08/19/2014CA2572707C Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
08/19/2014CA2490659C Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
08/14/2014WO2014124384A1 Compositions and methods for cancer therapy
08/14/2014WO2014124026A1 Immuno imaging agent for use with antibody-drug conjugate therapy
08/14/2014WO2014122228A1 Labelled compounds that bind to alpha-v-beta-3 integrin
08/14/2014US20140229115 Methods for diagnosing diseases and evaluating treatments therefor using pet
08/14/2014US20140228569 Novel compound having affinity for amyloid
08/14/2014US20140228551 Compositions, methods of synthesis and use of carbohydrate targeted agents
08/14/2014US20140227190 Fluorescent magnetic nanoprobes, methods of making, and methods of use
08/14/2014US20140227183 Small-molecule hsp90 inhibitors
08/14/2014US20140227182 Cancer imaging with therapy: theranostics
08/14/2014US20140227181 Method of labelling a biologically active molecule with 5-fluoro-5-deoxypentose or a 3-fluoro-3-deoxypentose
08/14/2014US20140227179 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/14/2014US20140227178 Humanized Anti-HLA-DR Antibodies
08/14/2014US20140227177 Scanning Suspension Comprising a Particle with a Diameter of at least 1 Micrometer
08/14/2014US20140227176 Radioactive and/or Magnetic Metal Nanoparticles and Process and Apparatus for Synthesizing Same
08/14/2014US20140227175 Cathepsin-binding compounds bound to a carrier and their diagnostic use
08/14/2014US20140227172 Diagnosis and treatment of prostate cancer
08/13/2014CN103977434A 一种对羟基苯甲酸介导的脑靶向聚合物胶束递药系统 A kind of brain-hydroxy acid-mediated drug delivery systems targeted polymeric micelles
08/13/2014CN102762230B 放射免疫偶联物和其用途 Radioimmunoconjugate and uses thereof
08/13/2014CN102186844B 放射性标记的甘氨酸1转运蛋白抑制剂 The radiolabeled glycine transporter 1 inhibitor
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 243